

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 4.43197637 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 4.43197637 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 4.37679363 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.37679363 |
| 5 | protein maturation by protein folding (GO:0022417) | 4.36422174 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 4.32242353 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.32242353 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 4.08649958 |
| 9 | skin morphogenesis (GO:0043589) | 3.87488751 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 3.86994512 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 3.86994512 |
| 12 | tryptophan catabolic process (GO:0006569) | 3.86994512 |
| 13 | sulfur amino acid catabolic process (GO:0000098) | 3.85423472 |
| 14 | protein carboxylation (GO:0018214) | 3.81233104 |
| 15 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.81233104 |
| 16 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.79994615 |
| 17 | cell adhesion mediated by integrin (GO:0033627) | 3.77685436 |
| 18 | cysteine metabolic process (GO:0006534) | 3.76051640 |
| 19 | tryptophan metabolic process (GO:0006568) | 3.71557634 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 3.63912728 |
| 21 | protein retention in ER lumen (GO:0006621) | 3.61620296 |
| 22 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.60225227 |
| 23 | glyoxylate metabolic process (GO:0046487) | 3.59772484 |
| 24 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.58969513 |
| 25 | kynurenine metabolic process (GO:0070189) | 3.58020443 |
| 26 | negative regulation of fibrinolysis (GO:0051918) | 3.44206655 |
| 27 | peptidyl-proline hydroxylation (GO:0019511) | 3.41227403 |
| 28 | lysine metabolic process (GO:0006553) | 3.41178591 |
| 29 | lysine catabolic process (GO:0006554) | 3.41178591 |
| 30 | desmosome organization (GO:0002934) | 3.40581674 |
| 31 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.36862417 |
| 32 | hemidesmosome assembly (GO:0031581) | 3.36458616 |
| 33 | homocysteine metabolic process (GO:0050667) | 3.34606213 |
| 34 | bile acid biosynthetic process (GO:0006699) | 3.33995835 |
| 35 | type B pancreatic cell proliferation (GO:0044342) | 3.32708740 |
| 36 | intestinal cholesterol absorption (GO:0030299) | 3.32063011 |
| 37 | valine metabolic process (GO:0006573) | 3.30798563 |
| 38 | axonemal dynein complex assembly (GO:0070286) | 3.29876289 |
| 39 | regulation of fibrinolysis (GO:0051917) | 3.27737291 |
| 40 | amino-acid betaine metabolic process (GO:0006577) | 3.27179009 |
| 41 | signal peptide processing (GO:0006465) | 3.20661783 |
| 42 | drug transmembrane transport (GO:0006855) | 3.20593898 |
| 43 | regulation of protein activation cascade (GO:2000257) | 3.17266510 |
| 44 | complement activation, alternative pathway (GO:0006957) | 3.16585039 |
| 45 | proline biosynthetic process (GO:0006561) | 3.16399558 |
| 46 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.16153807 |
| 47 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.13761105 |
| 48 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.13761105 |
| 49 | amyloid precursor protein catabolic process (GO:0042987) | 3.11280378 |
| 50 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.10136607 |
| 51 | high-density lipoprotein particle remodeling (GO:0034375) | 3.08490848 |
| 52 | protein hydroxylation (GO:0018126) | 3.07717293 |
| 53 | 4-hydroxyproline metabolic process (GO:0019471) | 3.06533816 |
| 54 | basement membrane organization (GO:0071711) | 3.05905216 |
| 55 | regulation of complement activation (GO:0030449) | 3.02889856 |
| 56 | GDP-mannose metabolic process (GO:0019673) | 3.00372152 |
| 57 | drug transport (GO:0015893) | 2.99123994 |
| 58 | regulation of cholesterol homeostasis (GO:2000188) | 2.95416689 |
| 59 | cellular modified amino acid catabolic process (GO:0042219) | 2.91900541 |
| 60 | aromatic amino acid family metabolic process (GO:0009072) | 2.91869099 |
| 61 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.91634375 |
| 62 | reverse cholesterol transport (GO:0043691) | 2.91198487 |
| 63 | bile acid metabolic process (GO:0008206) | 2.89581375 |
| 64 | keratan sulfate catabolic process (GO:0042340) | 2.88819613 |
| 65 | COPII vesicle coating (GO:0048208) | 2.87798588 |
| 66 | ethanol oxidation (GO:0006069) | 2.87410305 |
| 67 | proline metabolic process (GO:0006560) | 2.85184346 |
| 68 | urate metabolic process (GO:0046415) | 2.84016778 |
| 69 | urea metabolic process (GO:0019627) | 2.80723352 |
| 70 | urea cycle (GO:0000050) | 2.80723352 |
| 71 | regulation of triglyceride catabolic process (GO:0010896) | 2.79305817 |
| 72 | negative regulation of protein activation cascade (GO:2000258) | 2.78720236 |
| 73 | zinc ion transmembrane transport (GO:0071577) | 2.78579987 |
| 74 | bile acid and bile salt transport (GO:0015721) | 2.77593441 |
| 75 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.76175206 |
| 76 | regulation of plasminogen activation (GO:0010755) | 2.75295761 |
| 77 | phospholipid efflux (GO:0033700) | 2.74696067 |
| 78 | carnitine metabolic process (GO:0009437) | 2.74592017 |
| 79 | indolalkylamine metabolic process (GO:0006586) | 2.74269630 |
| 80 | serine family amino acid catabolic process (GO:0009071) | 2.73945532 |
| 81 | fatty acid beta-oxidation (GO:0006635) | 2.73849109 |
| 82 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.73845429 |
| 83 | fibrinolysis (GO:0042730) | 2.73806938 |
| 84 | nitrogen cycle metabolic process (GO:0071941) | 2.71687300 |
| 85 | negative regulation of cholesterol transport (GO:0032375) | 2.71525877 |
| 86 | negative regulation of sterol transport (GO:0032372) | 2.71525877 |
| 87 | peptide catabolic process (GO:0043171) | 2.70942922 |
| 88 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.70926467 |
| 89 | fatty acid oxidation (GO:0019395) | 2.70800298 |
| 90 | negative regulation of complement activation (GO:0045916) | 2.69936589 |
| 91 | cellular biogenic amine catabolic process (GO:0042402) | 2.69324788 |
| 92 | amine catabolic process (GO:0009310) | 2.69324788 |
| 93 | acylglycerol homeostasis (GO:0055090) | 2.69275802 |
| 94 | triglyceride homeostasis (GO:0070328) | 2.69275802 |
| 95 | serine family amino acid biosynthetic process (GO:0009070) | 2.69173586 |
| 96 | regulation of metalloenzyme activity (GO:0048552) | 2.68279683 |
| 97 | cellular glucuronidation (GO:0052695) | 2.67587245 |
| 98 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.66035075 |
| 99 | response to nitrosative stress (GO:0051409) | 2.65881895 |
| 100 | exocrine pancreas development (GO:0031017) | 2.65540396 |
| 101 | membrane protein ectodomain proteolysis (GO:0006509) | 2.65221082 |
| 102 | plasma lipoprotein particle clearance (GO:0034381) | 2.64450356 |
| 103 | plasma lipoprotein particle assembly (GO:0034377) | 2.63986638 |
| 104 | lipid oxidation (GO:0034440) | 2.63490975 |
| 105 | lipoprotein metabolic process (GO:0042157) | 2.63245548 |
| 106 | cellular copper ion homeostasis (GO:0006878) | 2.62129709 |
| 107 | protein-lipid complex remodeling (GO:0034368) | 2.61731754 |
| 108 | macromolecular complex remodeling (GO:0034367) | 2.61731754 |
| 109 | plasma lipoprotein particle remodeling (GO:0034369) | 2.61731754 |
| 110 | benzene-containing compound metabolic process (GO:0042537) | 2.61119655 |
| 111 | positive regulation of nuclease activity (GO:0032075) | 2.61030207 |
| 112 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.60800368 |
| 113 | L-serine transport (GO:0015825) | 2.60718637 |
| 114 | extracellular fibril organization (GO:0043206) | 2.60691164 |
| 115 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.60397583 |
| 116 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.60397583 |
| 117 | hyaluronan catabolic process (GO:0030214) | 2.59385581 |
| 118 | polyketide metabolic process (GO:0030638) | 2.58037016 |
| 119 | doxorubicin metabolic process (GO:0044598) | 2.58037016 |
| 120 | daunorubicin metabolic process (GO:0044597) | 2.58037016 |
| 121 | glucuronate metabolic process (GO:0019585) | 2.57142339 |
| 122 | uronic acid metabolic process (GO:0006063) | 2.57142339 |
| 123 | tricarboxylic acid metabolic process (GO:0072350) | 2.56970898 |
| 124 | serine family amino acid metabolic process (GO:0009069) | 2.56929247 |
| 125 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.56357572 |
| 126 | glycine metabolic process (GO:0006544) | 2.54616791 |
| 127 | aldehyde catabolic process (GO:0046185) | 2.54509350 |
| 128 | alpha-amino acid catabolic process (GO:1901606) | 2.53892991 |
| 129 | mannosylation (GO:0097502) | 2.53600229 |
| 130 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.53565049 |
| 131 | regulation of cholesterol esterification (GO:0010872) | 2.53458469 |
| 132 | protein-lipid complex assembly (GO:0065005) | 2.52461148 |
| 133 | opsonization (GO:0008228) | 2.52339740 |
| 134 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.51092948 |
| 135 | apoptotic cell clearance (GO:0043277) | 2.49688402 |
| 136 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.49409196 |
| 137 | regulation of cholesterol metabolic process (GO:0090181) | 2.49388630 |
| 138 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.48319857 |
| 139 | branched-chain amino acid metabolic process (GO:0009081) | 2.47900352 |
| 140 | primary alcohol catabolic process (GO:0034310) | 2.47822412 |
| 141 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.46972759 |
| 142 | sequestering of metal ion (GO:0051238) | 2.46692236 |
| 143 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.46181636 |
| 144 | cellular response to unfolded protein (GO:0034620) | 2.45313449 |
| 145 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.39408896 |
| 146 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.39032604 |
| 147 | muscle cell migration (GO:0014812) | 2.38924337 |
| 148 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.38717253 |
| 149 | vesicle coating (GO:0006901) | 2.38438092 |
| 150 | membrane budding (GO:0006900) | 2.37881508 |
| 151 | peptidyl-asparagine modification (GO:0018196) | 2.37549987 |
| 152 | protein N-linked glycosylation (GO:0006487) | 2.36849476 |
| 153 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.36452933 |
| 154 | zinc ion transport (GO:0006829) | 2.36381229 |
| 155 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.35622064 |
| 156 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.34863871 |
| 157 | lipopolysaccharide metabolic process (GO:0008653) | 2.34456912 |
| 158 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.34117056 |
| 159 | negative regulation of humoral immune response (GO:0002921) | 2.31916129 |
| 160 | glucose catabolic process (GO:0006007) | 2.30966868 |
| 161 | galactose catabolic process (GO:0019388) | 2.30649464 |
| 162 | cellular response to topologically incorrect protein (GO:0035967) | 2.30123036 |
| 163 | cellular zinc ion homeostasis (GO:0006882) | 2.28232316 |
| 164 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.25732730 |
| 165 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.25022083 |
| 166 | C-terminal protein lipidation (GO:0006501) | 2.24513233 |
| 167 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.24441648 |
| 168 | ER-nucleus signaling pathway (GO:0006984) | 2.24263078 |
| 169 | negative regulation of coagulation (GO:0050819) | 2.23495646 |
| 170 | barbed-end actin filament capping (GO:0051016) | 2.23145206 |
| 171 | gap junction assembly (GO:0016264) | 2.22718840 |
| 172 | regulation of nuclease activity (GO:0032069) | 2.22286024 |
| 173 | galactose metabolic process (GO:0006012) | 2.22154249 |
| 174 | endodermal cell differentiation (GO:0035987) | 2.21329002 |
| 175 | nuclear envelope reassembly (GO:0031468) | 2.20336549 |
| 176 | mitotic nuclear envelope reassembly (GO:0007084) | 2.20336549 |
| 177 | motile cilium assembly (GO:0044458) | 2.17523418 |
| 178 | wound healing, spreading of epidermal cells (GO:0035313) | 2.17323889 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.89276347 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.88422423 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.57587218 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.44281147 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.77829158 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.76840371 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.50000849 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.20462909 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.17626786 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.07531638 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.78644910 |
| 12 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.77294341 |
| 13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.44733481 |
| 14 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.37949530 |
| 15 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.35186622 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.33622629 |
| 17 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.32495548 |
| 18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.32327509 |
| 19 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.20125378 |
| 20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.18733779 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 2.14735880 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.09703860 |
| 23 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 2.00659483 |
| 24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.97244049 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92011058 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.84543309 |
| 27 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.78914328 |
| 28 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.77721283 |
| 29 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.77301829 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.73957673 |
| 31 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.71700303 |
| 32 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.64708722 |
| 33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.62204393 |
| 34 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.62059670 |
| 35 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.58487684 |
| 36 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.58347333 |
| 37 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.54946612 |
| 38 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.54923058 |
| 39 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.53315397 |
| 40 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.51420013 |
| 41 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.48768717 |
| 42 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.47754896 |
| 43 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47690390 |
| 44 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.47024330 |
| 45 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.46799912 |
| 46 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.46118149 |
| 47 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.45864258 |
| 48 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.45374562 |
| 49 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.44606527 |
| 50 | * TP53_22127205_ChIP-Seq_IMR90_Human | 1.43744368 |
| 51 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.42999127 |
| 52 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.42103785 |
| 53 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.41793238 |
| 54 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.37097999 |
| 55 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.36931454 |
| 56 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.34475641 |
| 57 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.32921104 |
| 58 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.32788449 |
| 59 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.31294498 |
| 60 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.30461497 |
| 61 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.26380682 |
| 62 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.25395424 |
| 63 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.25123315 |
| 64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.24919674 |
| 65 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.24556435 |
| 66 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.23686679 |
| 67 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.23437599 |
| 68 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.23028923 |
| 69 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.19840518 |
| 70 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.19626624 |
| 71 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.19481016 |
| 72 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.18914649 |
| 73 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.18252429 |
| 74 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.17516731 |
| 75 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.17232772 |
| 76 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.15224533 |
| 77 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.14630723 |
| 78 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.14621631 |
| 79 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.14129830 |
| 80 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13960366 |
| 81 | MAF_26560356_Chip-Seq_TH1_Human | 1.12963761 |
| 82 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.12858418 |
| 83 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12118412 |
| 84 | MYB_26560356_Chip-Seq_TH2_Human | 1.11339239 |
| 85 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11277058 |
| 86 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.10521165 |
| 87 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.10489451 |
| 88 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.10360505 |
| 89 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09656172 |
| 90 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09652416 |
| 91 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.09283333 |
| 92 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.09227727 |
| 93 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.08950640 |
| 94 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.08797039 |
| 95 | CJUN_26792858_Chip-Seq_BT549_Human | 1.08748928 |
| 96 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.08505688 |
| 97 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.07446393 |
| 98 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.07273572 |
| 99 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.07247965 |
| 100 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.06975595 |
| 101 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.06169411 |
| 102 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.05790364 |
| 103 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.05733395 |
| 104 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05555954 |
| 105 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.04014010 |
| 106 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.03385914 |
| 107 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.03270859 |
| 108 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.02984186 |
| 109 | MYC_22102868_ChIP-Seq_BL_Human | 1.02777593 |
| 110 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.02154399 |
| 111 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02093191 |
| 112 | MYB_26560356_Chip-Seq_TH1_Human | 1.01911090 |
| 113 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01534076 |
| 114 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.01437749 |
| 115 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00995132 |
| 116 | UTX_26944678_Chip-Seq_JUKART_Human | 1.00443934 |
| 117 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.00437460 |
| 118 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.00374544 |
| 119 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99410788 |
| 120 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99348604 |
| 121 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.99322682 |
| 122 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.98613842 |
| 123 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.97248561 |
| 124 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.97219925 |
| 125 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97176334 |
| 126 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.97173181 |
| 127 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.97026056 |
| 128 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.96994385 |
| 129 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.96993991 |
| 130 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.96781965 |
| 131 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.96475037 |
| 132 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.96430016 |
| 133 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.96404596 |
| 134 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96261417 |
| 135 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.96105661 |
| 136 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95774715 |
| 137 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.95420961 |
| 138 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.94981107 |
| 139 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93336869 |
| 140 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.93155211 |
| 141 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92304880 |
| 142 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92049049 |
| 143 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.90386186 |
| 144 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.90254059 |
| 145 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.89255034 |
| 146 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.89165514 |
| 147 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.89165514 |
| 148 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89004682 |
| 149 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.88688018 |
| 150 | ATF3_27146783_Chip-Seq_COLON_Human | 0.87882155 |
| 151 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.87360719 |
| 152 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.86117933 |
| 153 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85746285 |
| 154 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.85638460 |
| 155 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85400117 |
| 156 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.84888183 |
| 157 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.84507160 |
| 158 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.84291894 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.57936556 |
| 2 | MP0005360_urolithiasis | 4.07507620 |
| 3 | MP0005365_abnormal_bile_salt | 3.57809056 |
| 4 | MP0005257_abnormal_intraocular_pressure | 3.55762304 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.40381073 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 2.98960254 |
| 7 | MP0003252_abnormal_bile_duct | 2.76781521 |
| 8 | MP0009780_abnormal_chondrocyte_physiolo | 2.51761790 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.48680434 |
| 10 | MP0009840_abnormal_foam_cell | 2.46874904 |
| 11 | MP0005083_abnormal_biliary_tract | 2.35441105 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.22501655 |
| 13 | MP0003195_calcinosis | 2.14283923 |
| 14 | MP0006054_spinal_hemorrhage | 2.13862696 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.13151502 |
| 16 | MP0003705_abnormal_hypodermis_morpholog | 2.02898939 |
| 17 | MP0010030_abnormal_orbit_morphology | 1.95329401 |
| 18 | MP0003300_gastrointestinal_ulcer | 1.91136662 |
| 19 | MP0010329_abnormal_lipoprotein_level | 1.88501829 |
| 20 | MP0001849_ear_inflammation | 1.83108406 |
| 21 | MP0005408_hypopigmentation | 1.82427382 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 1.79217473 |
| 23 | MP0005623_abnormal_meninges_morphology | 1.78348149 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 1.77960348 |
| 25 | MP0008260_abnormal_autophagy | 1.76093850 |
| 26 | MP0003724_increased_susceptibility_to | 1.71748888 |
| 27 | MP0005332_abnormal_amino_acid | 1.70640664 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.69515607 |
| 29 | MP0005275_abnormal_skin_tensile | 1.65027666 |
| 30 | MP0003950_abnormal_plasma_membrane | 1.64415461 |
| 31 | MP0004019_abnormal_vitamin_homeostasis | 1.64335488 |
| 32 | MP0000516_abnormal_urinary_system | 1.59225266 |
| 33 | MP0005367_renal/urinary_system_phenotyp | 1.59225266 |
| 34 | MP0001542_abnormal_bone_strength | 1.55540319 |
| 35 | MP0004233_abnormal_muscle_weight | 1.55468455 |
| 36 | MP0005220_abnormal_exocrine_pancreas | 1.54740133 |
| 37 | MP0000609_abnormal_liver_physiology | 1.52255776 |
| 38 | MP0000013_abnormal_adipose_tissue | 1.47477359 |
| 39 | MP0004858_abnormal_nervous_system | 1.47361367 |
| 40 | MP0005058_abnormal_lysosome_morphology | 1.47232582 |
| 41 | MP0003279_aneurysm | 1.44184491 |
| 42 | MP0001958_emphysema | 1.41795946 |
| 43 | MP0001661_extended_life_span | 1.35623732 |
| 44 | MP0003436_decreased_susceptibility_to | 1.35210017 |
| 45 | MP0009053_abnormal_anal_canal | 1.33075140 |
| 46 | MP0003941_abnormal_skin_development | 1.32890586 |
| 47 | MP0005508_abnormal_skeleton_morphology | 1.31723072 |
| 48 | MP0003186_abnormal_redox_activity | 1.29446019 |
| 49 | MP0005164_abnormal_response_to | 1.27167367 |
| 50 | MP0005171_absent_coat_pigmentation | 1.25867676 |
| 51 | MP0005319_abnormal_enzyme/_coenzyme | 1.25198153 |
| 52 | MP0000467_abnormal_esophagus_morphology | 1.25016103 |
| 53 | MP0009384_cardiac_valve_regurgitation | 1.23871098 |
| 54 | MP0002060_abnormal_skin_morphology | 1.21764678 |
| 55 | MP0002282_abnormal_trachea_morphology | 1.21261365 |
| 56 | MP0000534_abnormal_ureter_morphology | 1.20911594 |
| 57 | MP0003942_abnormal_urinary_system | 1.18819090 |
| 58 | MP0003656_abnormal_erythrocyte_physiolo | 1.18187324 |
| 59 | MP0005503_abnormal_tendon_morphology | 1.18126228 |
| 60 | MP0002118_abnormal_lipid_homeostasis | 1.18008118 |
| 61 | MP0004272_abnormal_basement_membrane | 1.17351020 |
| 62 | MP0003566_abnormal_cell_adhesion | 1.17222582 |
| 63 | MP0005197_abnormal_uvea_morphology | 1.17193678 |
| 64 | MP0010234_abnormal_vibrissa_follicle | 1.15941806 |
| 65 | MP0000538_abnormal_urinary_bladder | 1.14498124 |
| 66 | MP0001835_abnormal_antigen_presentation | 1.08567072 |
| 67 | MP0000762_abnormal_tongue_morphology | 1.07337960 |
| 68 | MP0008469_abnormal_protein_level | 1.07262116 |
| 69 | MP0002933_joint_inflammation | 1.04922789 |
| 70 | MP0005023_abnormal_wound_healing | 1.04795646 |
| 71 | MP0005636_abnormal_mineral_homeostasis | 1.04362407 |
| 72 | MP0001533_abnormal_skeleton_physiology | 1.04291345 |
| 73 | MP0000598_abnormal_liver_morphology | 1.04267565 |
| 74 | MP0005084_abnormal_gallbladder_morpholo | 1.03887900 |
| 75 | MP0010368_abnormal_lymphatic_system | 1.02681305 |
| 76 | MP0002928_abnormal_bile_duct | 1.02351672 |
| 77 | MP0001243_abnormal_dermal_layer | 1.02205448 |
| 78 | MP0002909_abnormal_adrenal_gland | 1.02097671 |
| 79 | MP0005165_increased_susceptibility_to | 1.00556990 |
| 80 | MP0003868_abnormal_feces_composition | 0.99695183 |
| 81 | MP0009764_decreased_sensitivity_to | 0.99584520 |
| 82 | MP0005464_abnormal_platelet_physiology | 0.98665939 |
| 83 | MP0002136_abnormal_kidney_physiology | 0.98085732 |
| 84 | MP0000751_myopathy | 0.97868336 |
| 85 | MP0000003_abnormal_adipose_tissue | 0.96689395 |
| 86 | MP0001873_stomach_inflammation | 0.95215157 |
| 87 | MP0010155_abnormal_intestine_physiology | 0.95092700 |
| 88 | MP0002419_abnormal_innate_immunity | 0.94707829 |
| 89 | MP0000465_gastrointestinal_hemorrhage | 0.94452846 |
| 90 | MP0000358_abnormal_cell_content/ | 0.94346673 |
| 91 | MP0002132_abnormal_respiratory_system | 0.93590277 |
| 92 | MP0002166_altered_tumor_susceptibility | 0.93201855 |
| 93 | MP0001845_abnormal_inflammatory_respons | 0.92759245 |
| 94 | MP0003011_delayed_dark_adaptation | 0.92571087 |
| 95 | MP0000685_abnormal_immune_system | 0.89757945 |
| 96 | MP0001764_abnormal_homeostasis | 0.88505981 |
| 97 | MP0009763_increased_sensitivity_to | 0.88236980 |
| 98 | MP0001915_intracranial_hemorrhage | 0.88046438 |
| 99 | MP0009785_altered_susceptibility_to | 0.87657643 |
| 100 | MP0004264_abnormal_extraembryonic_tissu | 0.87279072 |
| 101 | MP0004947_skin_inflammation | 0.87169846 |
| 102 | MP0002089_abnormal_postnatal_growth/wei | 0.87143168 |
| 103 | MP0000678_abnormal_parathyroid_gland | 0.86926962 |
| 104 | MP0005025_abnormal_response_to | 0.86104072 |
| 105 | MP0001944_abnormal_pancreas_morphology | 0.86056202 |
| 106 | MP0001756_abnormal_urination | 0.85273728 |
| 107 | MP0005501_abnormal_skin_physiology | 0.84914284 |
| 108 | MP0003385_abnormal_body_wall | 0.84077849 |
| 109 | MP0000858_altered_metastatic_potential | 0.83309435 |
| 110 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.83166317 |
| 111 | MP0010771_integument_phenotype | 0.82824531 |
| 112 | MP0001216_abnormal_epidermal_layer | 0.82256469 |
| 113 | MP0005670_abnormal_white_adipose | 0.81982908 |
| 114 | MP0002396_abnormal_hematopoietic_system | 0.81939374 |
| 115 | MP0000579_abnormal_nail_morphology | 0.80854116 |
| 116 | MP0001790_abnormal_immune_system | 0.80325415 |
| 117 | MP0005387_immune_system_phenotype | 0.80325415 |
| 118 | MP0002254_reproductive_system_inflammat | 0.79953498 |
| 119 | MP0009333_abnormal_splenocyte_physiolog | 0.79394551 |
| 120 | MP0010352_gastrointestinal_tract_polyps | 0.78356178 |
| 121 | MP0003091_abnormal_cell_migration | 0.77058321 |
| 122 | MP0003303_peritoneal_inflammation | 0.76721908 |
| 123 | MP0000163_abnormal_cartilage_morphology | 0.76655267 |
| 124 | MP0000767_abnormal_smooth_muscle | 0.76497197 |
| 125 | MP0001270_distended_abdomen | 0.76064156 |
| 126 | MP0002938_white_spotting | 0.75470519 |
| 127 | MP0002896_abnormal_bone_mineralization | 0.75020926 |
| 128 | MP0005193_abnormal_anterior_eye | 0.74807594 |
| 129 | MP0002877_abnormal_melanocyte_morpholog | 0.74780339 |
| 130 | MP0009697_abnormal_copulation | 0.74300608 |
| 131 | MP0002693_abnormal_pancreas_physiology | 0.73130192 |
| 132 | MP0005595_abnormal_vascular_smooth | 0.72923122 |
| 133 | MP0009642_abnormal_blood_homeostasis | 0.72683241 |
| 134 | MP0000613_abnormal_salivary_gland | 0.71753914 |
| 135 | MP0003172_abnormal_lysosome_physiology | 0.71602989 |
| 136 | MP0005395_other_phenotype | 0.70814427 |
| 137 | MP0000371_diluted_coat_color | 0.70588649 |
| 138 | MP0005330_cardiomyopathy | 0.69823044 |
| 139 | MP0002168_other_aberrant_phenotype | 0.69714628 |
| 140 | MP0003453_abnormal_keratinocyte_physiol | 0.69701336 |
| 141 | MP0003795_abnormal_bone_structure | 0.69513546 |
| 142 | MP0000249_abnormal_blood_vessel | 0.69232862 |
| 143 | MP0002098_abnormal_vibrissa_morphology | 0.68800772 |
| 144 | MP0004883_abnormal_blood_vessel | 0.68732509 |
| 145 | MP0005410_abnormal_fertilization | 0.67986277 |
| 146 | MP0001853_heart_inflammation | 0.67298133 |
| 147 | MP0005451_abnormal_body_composition | 0.67265102 |
| 148 | MP0002135_abnormal_kidney_morphology | 0.66589953 |
| 149 | MP0005390_skeleton_phenotype | 0.66266717 |
| 150 | MP0004043_abnormal_pH_regulation | 0.65860321 |
| 151 | MP0002998_abnormal_bone_remodeling | 0.65409748 |
| 152 | MP0005000_abnormal_immune_tolerance | 0.64925057 |
| 153 | MP0002653_abnormal_ependyma_morphology | 0.64704519 |
| 154 | MP0004782_abnormal_surfactant_physiolog | 0.64630342 |
| 155 | MP0002452_abnormal_antigen_presenting | 0.64568666 |
| 156 | MP0002405_respiratory_system_inflammati | 0.62715146 |
| 157 | MP0002295_abnormal_pulmonary_circulatio | 0.62703615 |
| 158 | MP0001800_abnormal_humoral_immune | 0.60118880 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 4.26761751 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.22239302 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 4.14976534 |
| 4 | Deep venous thrombosis (HP:0002625) | 4.05925618 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.87639140 |
| 6 | Xanthomatosis (HP:0000991) | 3.84804600 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 3.45623525 |
| 8 | Abnormality of the intrinsic pathway (HP:0010989) | 3.37821333 |
| 9 | Short nail (HP:0001799) | 3.35191028 |
| 10 | Abnormality of the common coagulation pathway (HP:0010990) | 3.27974484 |
| 11 | Premature rupture of membranes (HP:0001788) | 3.18216700 |
| 12 | Abnormality of dentin (HP:0010299) | 3.14204744 |
| 13 | Generalized aminoaciduria (HP:0002909) | 3.04662288 |
| 14 | Vacuolated lymphocytes (HP:0001922) | 3.02736281 |
| 15 | Ketosis (HP:0001946) | 3.01631834 |
| 16 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.01135324 |
| 17 | Protrusio acetabuli (HP:0003179) | 2.99846929 |
| 18 | Nonimmune hydrops fetalis (HP:0001790) | 2.99468599 |
| 19 | Hypobetalipoproteinemia (HP:0003563) | 2.96936406 |
| 20 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.94468357 |
| 21 | Complement deficiency (HP:0004431) | 2.92900015 |
| 22 | Joint hemorrhage (HP:0005261) | 2.86691060 |
| 23 | Follicular hyperkeratosis (HP:0007502) | 2.86636889 |
| 24 | Fat malabsorption (HP:0002630) | 2.85408087 |
| 25 | Ketoacidosis (HP:0001993) | 2.84740453 |
| 26 | Hypoglycemic seizures (HP:0002173) | 2.84602105 |
| 27 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.84140881 |
| 28 | Conjugated hyperbilirubinemia (HP:0002908) | 2.83966538 |
| 29 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.72000677 |
| 30 | Myocardial infarction (HP:0001658) | 2.64631560 |
| 31 | Vascular tortuosity (HP:0004948) | 2.64066272 |
| 32 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.62336305 |
| 33 | Abnormality of glycolipid metabolism (HP:0010969) | 2.61883977 |
| 34 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.61883977 |
| 35 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.61883977 |
| 36 | Hypolipoproteinemia (HP:0010981) | 2.59249802 |
| 37 | Hypoalphalipoproteinemia (HP:0003233) | 2.54061397 |
| 38 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.53591302 |
| 39 | Mucopolysacchariduria (HP:0008155) | 2.53591302 |
| 40 | Hyperammonemia (HP:0001987) | 2.53142323 |
| 41 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.53089099 |
| 42 | Cardiovascular calcification (HP:0011915) | 2.52220073 |
| 43 | Glucose intolerance (HP:0000833) | 2.52110402 |
| 44 | Abnormality of purine metabolism (HP:0004352) | 2.51358644 |
| 45 | Hyperlipoproteinemia (HP:0010980) | 2.49712034 |
| 46 | Abnormality of carpal bone ossification (HP:0006257) | 2.48609353 |
| 47 | Abnormality of the umbilical cord (HP:0010881) | 2.46780112 |
| 48 | Abnormality of complement system (HP:0005339) | 2.46677353 |
| 49 | Arterial tortuosity (HP:0005116) | 2.46658677 |
| 50 | Abnormality of nucleobase metabolism (HP:0010932) | 2.45726117 |
| 51 | Hyperglycinuria (HP:0003108) | 2.42567635 |
| 52 | Vascular calcification (HP:0004934) | 2.42317321 |
| 53 | Hand muscle atrophy (HP:0009130) | 2.41844203 |
| 54 | Hyperbilirubinemia (HP:0002904) | 2.40644139 |
| 55 | Abnormality of the acetabulum (HP:0003170) | 2.40109250 |
| 56 | Upper limb amyotrophy (HP:0009129) | 2.39870069 |
| 57 | Distal upper limb amyotrophy (HP:0007149) | 2.39870069 |
| 58 | Natal tooth (HP:0000695) | 2.37976796 |
| 59 | Type I transferrin isoform profile (HP:0003642) | 2.36463337 |
| 60 | Cervical subluxation (HP:0003308) | 2.35377030 |
| 61 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.34461064 |
| 62 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.32297569 |
| 63 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.32297569 |
| 64 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.32297569 |
| 65 | Late onset (HP:0003584) | 2.31538318 |
| 66 | Peritonitis (HP:0002586) | 2.31420889 |
| 67 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.29653666 |
| 68 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.28415710 |
| 69 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.25528867 |
| 70 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.23963821 |
| 71 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.23167865 |
| 72 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.23167865 |
| 73 | Epidermoid cyst (HP:0200040) | 2.21885691 |
| 74 | Abnormal protein glycosylation (HP:0012346) | 2.21229733 |
| 75 | Abnormal glycosylation (HP:0012345) | 2.21229733 |
| 76 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.21229733 |
| 77 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.21229733 |
| 78 | Systemic lupus erythematosus (HP:0002725) | 2.21011951 |
| 79 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.20004136 |
| 80 | Steatorrhea (HP:0002570) | 2.19611158 |
| 81 | Mitral stenosis (HP:0001718) | 2.19265126 |
| 82 | Dicarboxylic aciduria (HP:0003215) | 2.18490457 |
| 83 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.18490457 |
| 84 | Ectopia lentis (HP:0001083) | 2.16095272 |
| 85 | Symptomatic seizures (HP:0011145) | 2.15222110 |
| 86 | Hepatocellular carcinoma (HP:0001402) | 2.14798029 |
| 87 | Atelectasis (HP:0100750) | 2.14624087 |
| 88 | Glomerulonephritis (HP:0000099) | 2.14616395 |
| 89 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.14499971 |
| 90 | Abnormality of glycine metabolism (HP:0010895) | 2.14499971 |
| 91 | Dysostosis multiplex (HP:0000943) | 2.13463156 |
| 92 | Esophageal varix (HP:0002040) | 2.13405846 |
| 93 | Abnormality of proline metabolism (HP:0010907) | 2.13017281 |
| 94 | Hydroxyprolinuria (HP:0003080) | 2.13017281 |
| 95 | Occipital encephalocele (HP:0002085) | 2.12814976 |
| 96 | Abnormal gallbladder physiology (HP:0012438) | 2.12770754 |
| 97 | Cholecystitis (HP:0001082) | 2.12770754 |
| 98 | Elbow flexion contracture (HP:0002987) | 2.10633791 |
| 99 | Rhinitis (HP:0012384) | 2.10591749 |
| 100 | Hypokinesia (HP:0002375) | 2.10340650 |
| 101 | Abnormal ciliary motility (HP:0012262) | 2.10289731 |
| 102 | Gout (HP:0001997) | 2.10007008 |
| 103 | Abnormal delivery (HP:0001787) | 2.08605216 |
| 104 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.08496958 |
| 105 | Fragile skin (HP:0001030) | 2.08219333 |
| 106 | Wormian bones (HP:0002645) | 2.06031610 |
| 107 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.04717426 |
| 108 | Proximal tubulopathy (HP:0000114) | 2.03473202 |
| 109 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.02163154 |
| 110 | Single umbilical artery (HP:0001195) | 2.02163154 |
| 111 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.02163154 |
| 112 | Abnormality of the Achilles tendon (HP:0005109) | 1.99271904 |
| 113 | Bladder diverticulum (HP:0000015) | 1.98822004 |
| 114 | Atrophic scars (HP:0001075) | 1.98508409 |
| 115 | Vertebral compression fractures (HP:0002953) | 1.98362758 |
| 116 | Elevated alkaline phosphatase (HP:0003155) | 1.97570511 |
| 117 | Aortic dissection (HP:0002647) | 1.96470614 |
| 118 | Opisthotonus (HP:0002179) | 1.95973461 |
| 119 | Menorrhagia (HP:0000132) | 1.94446070 |
| 120 | Achilles tendon contracture (HP:0001771) | 1.93510834 |
| 121 | Nephritis (HP:0000123) | 1.93093068 |
| 122 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.93069361 |
| 123 | Gingival bleeding (HP:0000225) | 1.92867126 |
| 124 | Reduced antithrombin III activity (HP:0001976) | 1.92601472 |
| 125 | Spinal rigidity (HP:0003306) | 1.92544397 |
| 126 | Ulnar bowing (HP:0003031) | 1.92087541 |
| 127 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.91955296 |
| 128 | Prolonged neonatal jaundice (HP:0006579) | 1.91846420 |
| 129 | Abnormality of methionine metabolism (HP:0010901) | 1.90916261 |
| 130 | Abnormal ossification of hand bones (HP:0005921) | 1.90856435 |
| 131 | Back pain (HP:0003418) | 1.90365004 |
| 132 | Beaking of vertebral bodies (HP:0004568) | 1.90037430 |
| 133 | Long toe (HP:0010511) | 1.89536337 |
| 134 | Aortic aneurysm (HP:0004942) | 1.88810789 |
| 135 | Entropion (HP:0000621) | 1.88769757 |
| 136 | Hemorrhage of the eye (HP:0011885) | 1.88333084 |
| 137 | Pterygium (HP:0001059) | 1.86914048 |
| 138 | Ovoid vertebral bodies (HP:0003300) | 1.86758019 |
| 139 | Microglossia (HP:0000171) | 1.86673287 |
| 140 | Abnormal cartilage morphology (HP:0002763) | 1.86438411 |
| 141 | Pancreatitis (HP:0001733) | 1.85671612 |
| 142 | Testicular atrophy (HP:0000029) | 1.84834990 |
| 143 | Generalized amyotrophy (HP:0003700) | 1.84546293 |
| 144 | Blue sclerae (HP:0000592) | 1.82381035 |
| 145 | Osteolytic defects of the hand bones (HP:0009699) | 1.81265853 |
| 146 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.81265853 |
| 147 | Metabolic acidosis (HP:0001942) | 1.80657151 |
| 148 | Coxa vara (HP:0002812) | 1.80422810 |
| 149 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.80321230 |
| 150 | Nuclear cataract (HP:0100018) | 1.79828728 |
| 151 | Abdominal distention (HP:0003270) | 1.79429013 |
| 152 | Spondylolisthesis (HP:0003302) | 1.78243973 |
| 153 | Joint stiffness (HP:0001387) | 1.78114279 |
| 154 | Insulin resistance (HP:0000855) | 1.78061649 |
| 155 | Soft skin (HP:0000977) | 1.77997977 |
| 156 | Flat acetabular roof (HP:0003180) | 1.77412937 |
| 157 | Rough bone trabeculation (HP:0100670) | 1.77376214 |
| 158 | Biconcave vertebral bodies (HP:0004586) | 1.77258380 |
| 159 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.76945023 |
| 160 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.76945023 |
| 161 | Ankle contracture (HP:0006466) | 1.75317323 |
| 162 | White forelock (HP:0002211) | 1.74846779 |
| 163 | Patchy hypopigmentation of hair (HP:0011365) | 1.74455210 |
| 164 | Abnormal hand bone ossification (HP:0010660) | 1.72909899 |
| 165 | Skin nodule (HP:0200036) | 1.72138353 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.22369249 |
| 2 | BCKDK | 3.52055049 |
| 3 | SIK1 | 2.88942666 |
| 4 | TRIB3 | 2.73149296 |
| 5 | INSRR | 2.60149131 |
| 6 | IRAK3 | 2.56268234 |
| 7 | LIMK1 | 2.55734271 |
| 8 | LMTK2 | 2.46725994 |
| 9 | KDR | 2.37140076 |
| 10 | FLT3 | 2.31771877 |
| 11 | PKN2 | 2.14297083 |
| 12 | FGFR4 | 2.03881954 |
| 13 | ARAF | 2.02875902 |
| 14 | EPHA2 | 2.01408374 |
| 15 | EIF2AK1 | 1.94345896 |
| 16 | MAPKAPK3 | 1.93934084 |
| 17 | PTK6 | 1.90306948 |
| 18 | VRK2 | 1.86689495 |
| 19 | BLK | 1.84549309 |
| 20 | MAP4K1 | 1.81827252 |
| 21 | TAOK3 | 1.75827231 |
| 22 | RIPK1 | 1.71178606 |
| 23 | NEK9 | 1.66475454 |
| 24 | MAP3K10 | 1.64750365 |
| 25 | TYK2 | 1.62492664 |
| 26 | IRAK4 | 1.61202465 |
| 27 | NTRK1 | 1.58039088 |
| 28 | TGFBR2 | 1.55083102 |
| 29 | ICK | 1.51334952 |
| 30 | MAP3K12 | 1.47561726 |
| 31 | JAK3 | 1.47123940 |
| 32 | NEK1 | 1.42634266 |
| 33 | ZAP70 | 1.41646921 |
| 34 | LRRK2 | 1.37167504 |
| 35 | PASK | 1.36392922 |
| 36 | SMG1 | 1.35945095 |
| 37 | MAP3K3 | 1.33904718 |
| 38 | PTK2 | 1.33631468 |
| 39 | PRKD2 | 1.31436198 |
| 40 | NME2 | 1.30568737 |
| 41 | TBK1 | 1.23882615 |
| 42 | CSK | 1.21727853 |
| 43 | MAPK15 | 1.21695772 |
| 44 | LATS1 | 1.19542554 |
| 45 | JAK1 | 1.18447277 |
| 46 | MST1R | 1.18339050 |
| 47 | STK10 | 1.17728009 |
| 48 | TIE1 | 1.15109940 |
| 49 | PIK3CG | 1.12644742 |
| 50 | MYLK | 1.12575736 |
| 51 | TEC | 1.11476849 |
| 52 | ERBB4 | 1.09496608 |
| 53 | EPHB1 | 1.07502120 |
| 54 | PDK2 | 1.07338063 |
| 55 | TTN | 1.06599361 |
| 56 | PRKCI | 1.03883969 |
| 57 | MAP2K3 | 1.03361549 |
| 58 | PTK2B | 1.01647577 |
| 59 | TESK1 | 1.01401500 |
| 60 | MAP3K14 | 1.00554587 |
| 61 | BTK | 0.99352844 |
| 62 | RPS6KA4 | 0.96153005 |
| 63 | TESK2 | 0.95858801 |
| 64 | CDK8 | 0.95607307 |
| 65 | PAK4 | 0.95500161 |
| 66 | MAP2K2 | 0.94661241 |
| 67 | BCR | 0.93420039 |
| 68 | PIM2 | 0.93053819 |
| 69 | PDGFRA | 0.92336271 |
| 70 | STK38 | 0.88927034 |
| 71 | KIT | 0.86358946 |
| 72 | IRAK1 | 0.86062755 |
| 73 | CSF1R | 0.85967170 |
| 74 | IKBKE | 0.84143724 |
| 75 | CDK7 | 0.83579557 |
| 76 | MET | 0.81313999 |
| 77 | PIK3CA | 0.79436974 |
| 78 | EEF2K | 0.78526680 |
| 79 | STK3 | 0.78100456 |
| 80 | TRPM7 | 0.77423307 |
| 81 | PRKD3 | 0.77002281 |
| 82 | PBK | 0.76359521 |
| 83 | EPHA3 | 0.75927542 |
| 84 | MUSK | 0.75512146 |
| 85 | DDR2 | 0.74375857 |
| 86 | CSNK1G3 | 0.73313523 |
| 87 | CSNK1A1L | 0.72568365 |
| 88 | MAP3K11 | 0.71311025 |
| 89 | DYRK1B | 0.71080657 |
| 90 | FRK | 0.70137816 |
| 91 | STK16 | 0.69835182 |
| 92 | ITK | 0.69731317 |
| 93 | PAK2 | 0.69547604 |
| 94 | ILK | 0.69141490 |
| 95 | BRSK1 | 0.68700426 |
| 96 | CDK9 | 0.65853005 |
| 97 | WNK4 | 0.65810687 |
| 98 | JAK2 | 0.63777831 |
| 99 | MAPK11 | 0.61215340 |
| 100 | SCYL2 | 0.61167359 |
| 101 | NLK | 0.58802466 |
| 102 | PRKG2 | 0.57151732 |
| 103 | CDK6 | 0.56834639 |
| 104 | GSK3A | 0.55943208 |
| 105 | CCNB1 | 0.55248443 |
| 106 | MOS | 0.54332342 |
| 107 | GRK1 | 0.53944106 |
| 108 | IKBKB | 0.53421284 |
| 109 | NUAK1 | 0.52968280 |
| 110 | CAMK2G | 0.52730591 |
| 111 | AURKA | 0.52590156 |
| 112 | STK24 | 0.52227708 |
| 113 | RPS6KA2 | 0.51767651 |
| 114 | CHUK | 0.50383379 |
| 115 | BUB1 | 0.49931853 |
| 116 | LYN | 0.49736546 |
| 117 | TXK | 0.49695723 |
| 118 | CSNK1G1 | 0.49157451 |
| 119 | EPHB2 | 0.48289965 |
| 120 | TAOK1 | 0.47957321 |
| 121 | TTK | 0.47743788 |
| 122 | AKT2 | 0.47379083 |
| 123 | MAPKAPK2 | 0.46566107 |
| 124 | BRSK2 | 0.45734593 |
| 125 | LATS2 | 0.44914727 |
| 126 | STK38L | 0.43341474 |
| 127 | MTOR | 0.42120581 |
| 128 | MAP3K8 | 0.41629395 |
| 129 | FER | 0.41154975 |
| 130 | EIF2AK3 | 0.39745212 |
| 131 | ROCK2 | 0.39705234 |
| 132 | ADRBK1 | 0.39650317 |
| 133 | IGF1R | 0.39235585 |
| 134 | LCK | 0.39231053 |
| 135 | ROCK1 | 0.39094242 |
| 136 | PAK1 | 0.39058797 |
| 137 | IRAK2 | 0.38696672 |
| 138 | PRKD1 | 0.38461756 |
| 139 | PDGFRB | 0.35923871 |
| 140 | ERBB2 | 0.35859520 |
| 141 | ABL2 | 0.35750362 |
| 142 | MST4 | 0.35471103 |
| 143 | STK4 | 0.35061216 |
| 144 | NME1 | 0.35028506 |
| 145 | TGFBR1 | 0.34536045 |
| 146 | CAMK2D | 0.33656762 |
| 147 | FGFR1 | 0.33371352 |
| 148 | GRK6 | 0.31697233 |
| 149 | CSNK1G2 | 0.31690111 |
| 150 | MAP3K7 | 0.31640100 |
| 151 | MAP2K1 | 0.30502585 |
| 152 | PRKCE | 0.26848717 |
| 153 | PLK2 | 0.26005475 |
| 154 | SRC | 0.25319468 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.05973926 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.90523289 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.71296381 |
| 4 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.51209112 |
| 5 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.48021512 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.45047522 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.25548531 |
| 8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.12579820 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.12544872 |
| 10 | Proteasome_Homo sapiens_hsa03050 | 2.11183022 |
| 11 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.07339640 |
| 12 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.85904862 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.83443374 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.80582168 |
| 15 | Protein export_Homo sapiens_hsa03060 | 1.80408168 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 1.79450103 |
| 17 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.78784652 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.78702485 |
| 19 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.77289970 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.75023726 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.68294229 |
| 22 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.58906192 |
| 23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.58839724 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.58562557 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.57938622 |
| 26 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.56911158 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.51768498 |
| 28 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.51502935 |
| 29 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.51275208 |
| 30 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.50117185 |
| 31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.48693176 |
| 32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.47394198 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.47056105 |
| 34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.45516337 |
| 35 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.43719242 |
| 36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.42343842 |
| 37 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.41341342 |
| 38 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.40069183 |
| 39 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.36115803 |
| 40 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.35449956 |
| 41 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.34567121 |
| 42 | Other glycan degradation_Homo sapiens_hsa00511 | 1.33364895 |
| 43 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.27787254 |
| 44 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.27476343 |
| 45 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.26886668 |
| 46 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.26398338 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.24483824 |
| 48 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.23906811 |
| 49 | Retinol metabolism_Homo sapiens_hsa00830 | 1.23748920 |
| 50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.15868016 |
| 51 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.12710736 |
| 52 | Lysine degradation_Homo sapiens_hsa00310 | 1.11907490 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 1.11423620 |
| 54 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.09955336 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.09623127 |
| 56 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.07831894 |
| 57 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.02204431 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99213863 |
| 59 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.99197410 |
| 60 | Bile secretion_Homo sapiens_hsa04976 | 0.98621639 |
| 61 | Lysosome_Homo sapiens_hsa04142 | 0.97267068 |
| 62 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.96636696 |
| 63 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.94469220 |
| 64 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.94145025 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93554075 |
| 66 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.91548775 |
| 67 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.86916859 |
| 68 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.86354110 |
| 69 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.85445887 |
| 70 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.83217544 |
| 71 | Carbon metabolism_Homo sapiens_hsa01200 | 0.82455710 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.82056628 |
| 73 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.79834800 |
| 74 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.77041462 |
| 75 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.75110348 |
| 76 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.74302230 |
| 77 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.73044094 |
| 78 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.71949234 |
| 79 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.66801473 |
| 80 | Base excision repair_Homo sapiens_hsa03410 | 0.66663826 |
| 81 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.65665517 |
| 82 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.63793536 |
| 83 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.63299759 |
| 84 | Leishmaniasis_Homo sapiens_hsa05140 | 0.55631621 |
| 85 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.54958906 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.53562464 |
| 87 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.53426456 |
| 88 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.53005550 |
| 89 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.52487076 |
| 90 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.51876753 |
| 91 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.51584105 |
| 92 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.51128588 |
| 93 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.50742512 |
| 94 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50534143 |
| 95 | Legionellosis_Homo sapiens_hsa05134 | 0.50263324 |
| 96 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.48500520 |
| 97 | Malaria_Homo sapiens_hsa05144 | 0.48348582 |
| 98 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.47552782 |
| 99 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.46526062 |
| 100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46426023 |
| 101 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.45523916 |
| 102 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.42440380 |
| 103 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40795904 |
| 104 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.40028261 |
| 105 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.37667600 |
| 106 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.36293737 |
| 107 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.35782669 |
| 108 | Pertussis_Homo sapiens_hsa05133 | 0.35776106 |
| 109 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.34399563 |
| 110 | Mineral absorption_Homo sapiens_hsa04978 | 0.33732189 |
| 111 | Huntingtons disease_Homo sapiens_hsa05016 | 0.33716602 |
| 112 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.33555452 |
| 113 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33485967 |
| 114 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.33397276 |
| 115 | Prion diseases_Homo sapiens_hsa05020 | 0.33336369 |
| 116 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.31804461 |
| 117 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.31670611 |
| 118 | Measles_Homo sapiens_hsa05162 | 0.29893259 |
| 119 | Amoebiasis_Homo sapiens_hsa05146 | 0.29796291 |
| 120 | Bladder cancer_Homo sapiens_hsa05219 | 0.27399745 |
| 121 | Focal adhesion_Homo sapiens_hsa04510 | 0.26267033 |
| 122 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.26219015 |
| 123 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25896732 |
| 124 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.22445832 |
| 125 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.22322159 |
| 126 | Hepatitis C_Homo sapiens_hsa05160 | 0.20476976 |
| 127 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.19991817 |

